Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp219
|
ENSMUSG00000049295.10 | zinc finger protein 219 |
Zfp740
|
ENSMUSG00000046897.10 | zinc finger protein 740 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_52010292_52011175 | Zfp219 | 149 | 0.890329 | -0.91 | 2.2e-22 | Click! |
chr14_52010026_52010204 | Zfp219 | 460 | 0.618279 | -0.84 | 1.1e-15 | Click! |
chr14_52009451_52009674 | Zfp219 | 1013 | 0.297990 | -0.82 | 2.0e-14 | Click! |
chr14_52011290_52011441 | Zfp219 | 483 | 0.596343 | -0.81 | 7.7e-14 | Click! |
chr14_52006289_52006909 | Zfp219 | 1077 | 0.266677 | -0.81 | 9.7e-14 | Click! |
chr15_102198893_102199190 | Zfp740 | 4208 | 0.114978 | 0.69 | 5.9e-09 | Click! |
chr15_102203088_102203273 | Zfp740 | 69 | 0.708145 | 0.69 | 8.0e-09 | Click! |
chr15_102203424_102203965 | Zfp740 | 3 | 0.494630 | 0.65 | 8.8e-08 | Click! |
chr15_102205874_102206082 | Zfp740 | 581 | 0.521672 | -0.60 | 1.1e-06 | Click! |
chr15_102202881_102203055 | Zfp740 | 281 | 0.602128 | 0.37 | 6.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_137530580_137532081 | 41.01 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr14_55824498_55825973 | 34.98 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr12_69758521_69758986 | 31.51 |
Mir681 |
microRNA 681 |
5191 |
0.14 |
chr9_109094576_109096217 | 31.34 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr2_174329445_174331091 | 30.77 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr4_88032518_88033581 | 30.59 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr11_3289074_3290615 | 30.38 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr15_81585272_81586453 | 30.19 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr11_94468409_94469097 | 29.98 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4888 |
0.15 |
chr5_134313726_134314672 | 25.25 |
Gtf2i |
general transcription factor II I |
179 |
0.92 |
chr17_46857818_46858430 | 24.78 |
Bicral |
BRD4 interacting chromatin remodeling complex associated protein like |
358 |
0.84 |
chr6_125095392_125097556 | 24.35 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr14_75178641_75178799 | 22.37 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2512 |
0.23 |
chr18_79257106_79257504 | 22.14 |
Gm2116 |
predicted gene 2116 |
47857 |
0.15 |
chrX_123271195_123271712 | 21.55 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr2_156840246_156841082 | 21.33 |
Tgif2 |
TGFB-induced factor homeobox 2 |
358 |
0.63 |
chr17_12741201_12741959 | 20.95 |
Airn |
antisense Igf2r RNA |
182 |
0.93 |
chr4_140701770_140702866 | 20.87 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr18_35848127_35849279 | 20.56 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chrX_38564049_38565657 | 20.48 |
Cul4b |
cullin 4B |
191 |
0.95 |
chr17_34836344_34837687 | 20.35 |
Dxo |
decapping exoribonuclease |
4 |
0.52 |
chr15_58140746_58142050 | 20.00 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr11_78069241_78069397 | 19.60 |
Mir144 |
microRNA 144 |
3686 |
0.09 |
chr17_47909349_47909983 | 18.92 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr2_153492229_153493481 | 18.28 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr9_35105556_35106095 | 18.02 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
842 |
0.54 |
chr14_70074487_70075571 | 17.95 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr3_30507827_30509444 | 17.88 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr18_54422226_54422400 | 17.44 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
18 |
0.99 |
chr18_35829993_35830906 | 17.32 |
Cxxc5 |
CXXC finger 5 |
135 |
0.85 |
chr1_34389196_34389610 | 17.29 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr13_111940877_111941182 | 17.21 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr11_98766610_98767640 | 16.99 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3301 |
0.13 |
chr17_88065293_88066116 | 16.96 |
Fbxo11 |
F-box protein 11 |
413 |
0.86 |
chrX_142680720_142682167 | 16.93 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr12_12509201_12509901 | 16.51 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
116936 |
0.06 |
chr7_25249061_25250506 | 16.50 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr17_29500538_29500689 | 16.46 |
Pim1 |
proviral integration site 1 |
7206 |
0.11 |
chr6_5297603_5298489 | 16.35 |
Pon2 |
paraoxonase 2 |
284 |
0.91 |
chr3_144201827_144203140 | 16.34 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
chr17_47594139_47594990 | 16.30 |
Ccnd3 |
cyclin D3 |
192 |
0.9 |
chrX_136171094_136171425 | 15.93 |
Tceal8 |
transcription elongation factor A (SII)-like 8 |
942 |
0.41 |
chr3_89393362_89393859 | 15.92 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
25 |
0.89 |
chr7_17059591_17061170 | 15.90 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr14_76520183_76520537 | 15.82 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6232 |
0.21 |
chr15_102017591_102018334 | 15.72 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr12_80112847_80113228 | 15.58 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
24 |
0.96 |
chr7_36697059_36698174 | 15.45 |
Tshz3 |
teashirt zinc finger family member 3 |
502 |
0.7 |
chr5_100567324_100567596 | 15.43 |
Plac8 |
placenta-specific 8 |
4037 |
0.16 |
chr4_132077386_132077728 | 15.33 |
Epb41 |
erythrocyte membrane protein band 4.1 |
2236 |
0.17 |
chr2_165884402_165885933 | 15.27 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr15_103239260_103239668 | 15.20 |
Cbx5 |
chromobox 5 |
352 |
0.7 |
chr8_120486990_120488549 | 15.04 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr4_46404152_46404582 | 14.91 |
Hemgn |
hemogen |
131 |
0.94 |
chr12_76670569_76670894 | 14.83 |
Sptb |
spectrin beta, erythrocytic |
39292 |
0.14 |
chr11_105181488_105182080 | 14.63 |
Tlk2 |
tousled-like kinase 2 (Arabidopsis) |
9 |
0.84 |
chr11_4543369_4543542 | 14.54 |
Mtmr3 |
myotubularin related protein 3 |
2813 |
0.24 |
chr9_21615608_21616677 | 14.50 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr6_124919273_124920636 | 14.32 |
Ptms |
parathymosin |
149 |
0.88 |
chr6_72279340_72279553 | 13.99 |
Sftpb |
surfactant associated protein B |
25164 |
0.11 |
chr17_4994082_4994454 | 13.96 |
Arid1b |
AT rich interactive domain 1B (SWI-like) |
64 |
0.98 |
chrX_42067696_42069057 | 13.63 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr15_98608664_98610204 | 13.59 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr4_41135373_41135524 | 13.56 |
Ube2r2 |
ubiquitin-conjugating enzyme E2R 2 |
295 |
0.81 |
chr6_124931155_124931871 | 13.47 |
Mlf2 |
myeloid leukemia factor 2 |
37 |
0.94 |
chr6_138424907_138425582 | 13.41 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr1_132368268_132368561 | 13.21 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
527 |
0.69 |
chr11_117782445_117782614 | 13.18 |
Tmc8 |
transmembrane channel-like gene family 8 |
129 |
0.72 |
chr19_14596815_14596966 | 12.96 |
Tle4 |
transducin-like enhancer of split 4 |
1161 |
0.62 |
chr10_128804096_128805293 | 12.94 |
Tmem198b |
transmembrane protein 198b |
324 |
0.61 |
chr1_135731863_135732606 | 12.93 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr19_55192870_55193209 | 12.77 |
Mir6715 |
microRNA 6715 |
361 |
0.77 |
chr5_137510563_137511218 | 12.75 |
Gm8066 |
predicted gene 8066 |
637 |
0.45 |
chr9_100643446_100643943 | 12.74 |
Stag1 |
stromal antigen 1 |
58 |
0.97 |
chr19_45657916_45658214 | 12.69 |
Fbxw4 |
F-box and WD-40 domain protein 4 |
2247 |
0.31 |
chrX_20425156_20426396 | 12.50 |
Jade3 |
jade family PHD finger 3 |
12 |
0.97 |
chr9_32400635_32401003 | 12.44 |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
6834 |
0.18 |
chr15_67151184_67151505 | 12.41 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
22321 |
0.23 |
chr1_91448754_91448938 | 12.34 |
Per2 |
period circadian clock 2 |
1019 |
0.39 |
chr11_69096542_69097348 | 12.33 |
Per1 |
period circadian clock 1 |
1728 |
0.15 |
chr10_128525093_128526268 | 12.28 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr12_80103423_80104027 | 12.28 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr2_158168861_158169223 | 12.25 |
Tgm2 |
transglutaminase 2, C polypeptide |
22606 |
0.13 |
chr2_160603252_160603413 | 12.24 |
Gm14221 |
predicted gene 14221 |
16639 |
0.16 |
chr15_100324140_100324483 | 12.22 |
Mettl7a3 |
methyltransferase like 7A3 |
10618 |
0.1 |
chr12_76670352_76670547 | 12.11 |
Sptb |
spectrin beta, erythrocytic |
39574 |
0.14 |
chr15_96284787_96285378 | 12.06 |
2610037D02Rik |
RIKEN cDNA 2610037D02 gene |
587 |
0.72 |
chr4_149399188_149399413 | 12.04 |
Ube4b |
ubiquitination factor E4B |
78 |
0.96 |
chr11_101259341_101259883 | 12.04 |
Wnk4 |
WNK lysine deficient protein kinase 4 |
955 |
0.28 |
chr19_45541253_45541653 | 12.03 |
Poll |
polymerase (DNA directed), lambda |
19078 |
0.16 |
chr11_70468019_70468408 | 11.98 |
Zmynd15 |
zinc finger, MYND-type containing 15 |
7648 |
0.07 |
chr19_46984328_46984495 | 11.95 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
14843 |
0.14 |
chr5_111843336_111843953 | 11.88 |
Gm36535 |
predicted gene, 36535 |
50257 |
0.13 |
chr5_5186422_5186573 | 11.85 |
Cdk14 |
cyclin-dependent kinase 14 |
8858 |
0.17 |
chr16_94568896_94569342 | 11.84 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
891 |
0.6 |
chr14_115040506_115042372 | 11.84 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chrX_101299536_101300464 | 11.81 |
Nlgn3 |
neuroligin 3 |
474 |
0.66 |
chrX_36988645_36990253 | 11.79 |
Septin6 |
septin 6 |
42 |
0.97 |
chr4_101355840_101357064 | 11.66 |
E130102H24Rik |
RIKEN cDNA E130102H24 gene |
204 |
0.88 |
chr2_75703696_75705127 | 11.63 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr8_114117215_114117558 | 11.57 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
16171 |
0.27 |
chr2_30200503_30200691 | 11.53 |
Kyat1 |
kynurenine aminotransferase 1 |
2238 |
0.16 |
chr10_127508848_127510720 | 11.46 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr5_149649169_149649529 | 11.45 |
Gm20005 |
predicted gene, 20005 |
7739 |
0.14 |
chr13_45389281_45390472 | 11.41 |
Mylip |
myosin regulatory light chain interacting protein |
134 |
0.97 |
chr13_119232734_119232969 | 11.34 |
Gm44488 |
predicted gene, 44488 |
36753 |
0.17 |
chr17_47923769_47925323 | 11.26 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr1_119541086_119541484 | 11.26 |
3830432H09Rik |
RIKEN cDNA 3830432H09 gene |
5120 |
0.13 |
chr7_45814584_45814807 | 11.23 |
Cyth2 |
cytohesin 2 |
114 |
0.85 |
chr2_168072526_168073106 | 11.15 |
Gm24327 |
predicted gene, 24327 |
7919 |
0.14 |
chr5_135013108_135013523 | 11.15 |
Abhd11os |
abhydrolase domain containing 11, opposite strand |
62 |
0.92 |
chr10_80433030_80433838 | 11.13 |
Tcf3 |
transcription factor 3 |
187 |
0.88 |
chr11_77607040_77608322 | 11.11 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr9_72441151_72441302 | 11.09 |
Gm36948 |
predicted gene, 36948 |
466 |
0.43 |
chr4_131873537_131874159 | 11.09 |
Srsf4 |
serine and arginine-rich splicing factor 4 |
32 |
0.96 |
chr1_36539232_36539550 | 11.05 |
Gm42417 |
predicted gene, 42417 |
33 |
0.94 |
chr15_76697423_76698657 | 11.05 |
Gpt |
glutamic pyruvic transaminase, soluble |
22 |
0.93 |
chr7_101108669_101109239 | 10.94 |
Fchsd2 |
FCH and double SH3 domains 2 |
72 |
0.97 |
chr19_45015990_45016770 | 10.89 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
117 |
0.93 |
chr9_107982639_107983011 | 10.82 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
200 |
0.49 |
chr2_29973635_29973786 | 10.82 |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
4670 |
0.13 |
chr4_133103976_133104195 | 10.82 |
Wasf2 |
WAS protein family, member 2 |
26420 |
0.14 |
chr3_86799443_86799675 | 10.80 |
Dclk2 |
doublecortin-like kinase 2 |
399 |
0.86 |
chr15_78928102_78928484 | 10.76 |
Lgals1 |
lectin, galactose binding, soluble 1 |
1567 |
0.18 |
chr6_117906969_117907914 | 10.72 |
4933440N22Rik |
RIKEN cDNA 4933440N22 gene |
318 |
0.64 |
chr1_166002288_166003185 | 10.68 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr16_56075244_56076135 | 10.67 |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
209 |
0.9 |
chr1_167802317_167803268 | 10.66 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr10_80147802_80148562 | 10.61 |
Midn |
midnolin |
90 |
0.92 |
chr1_171203965_171204116 | 10.61 |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
7772 |
0.08 |
chr16_45927578_45927797 | 10.60 |
Gm15640 |
predicted gene 15640 |
8636 |
0.17 |
chr15_93591772_93592313 | 10.58 |
Prickle1 |
prickle planar cell polarity protein 1 |
3849 |
0.31 |
chr17_46555466_46556535 | 10.57 |
Srf |
serum response factor |
175 |
0.9 |
chrX_162736240_162736751 | 10.57 |
Gm15201 |
predicted gene 15201 |
118 |
0.95 |
chr8_11457961_11458212 | 10.53 |
Gm20100 |
predicted gene, 20100 |
1656 |
0.26 |
chr10_26374889_26375811 | 10.52 |
L3mbtl3 |
L3MBTL3 histone methyl-lysine binding protein |
165 |
0.94 |
chr1_134559997_134561478 | 10.51 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr15_80083248_80084015 | 10.45 |
Rpl3 |
ribosomal protein L3 |
225 |
0.75 |
chr4_117210425_117210673 | 10.44 |
Gm23287 |
predicted gene, 23287 |
295 |
0.76 |
chr19_53780948_53781123 | 10.43 |
Rbm20 |
RNA binding motif protein 20 |
12273 |
0.17 |
chr2_84937872_84938023 | 10.36 |
Slc43a3 |
solute carrier family 43, member 3 |
1057 |
0.4 |
chr3_87905763_87907208 | 10.35 |
Hdgf |
heparin binding growth factor |
164 |
0.9 |
chr1_36272382_36272841 | 10.34 |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
824 |
0.56 |
chr4_141545541_141546268 | 10.33 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
285 |
0.86 |
chr2_45116523_45117562 | 10.30 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
353 |
0.88 |
chr18_61501637_61501788 | 10.26 |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
7567 |
0.13 |
chr11_101189548_101190158 | 10.22 |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
4569 |
0.09 |
chr10_108447716_108447867 | 10.21 |
Gm36283 |
predicted gene, 36283 |
1189 |
0.49 |
chr2_165404944_165405246 | 10.20 |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
3971 |
0.15 |
chr11_5506298_5506508 | 10.18 |
Gm11963 |
predicted gene 11963 |
7563 |
0.13 |
chr2_152346974_152347129 | 10.16 |
Gm14164 |
predicted gene 14164 |
1382 |
0.24 |
chr8_70609185_70610414 | 10.14 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr9_61373312_61374646 | 10.13 |
Tle3 |
transducin-like enhancer of split 3 |
307 |
0.87 |
chr3_86224766_86224976 | 10.12 |
Lrba |
LPS-responsive beige-like anchor |
191 |
0.93 |
chr15_101176889_101177063 | 10.10 |
Acvr1b |
activin A receptor, type 1B |
2909 |
0.15 |
chr13_114987097_114987359 | 10.09 |
Gm47776 |
predicted gene, 47776 |
52160 |
0.12 |
chr6_143068606_143068801 | 10.06 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
1618 |
0.37 |
chr12_111009548_111009699 | 10.04 |
Gm48631 |
predicted gene, 48631 |
8779 |
0.12 |
chr15_79285406_79285956 | 10.04 |
Baiap2l2 |
BAI1-associated protein 2-like 2 |
144 |
0.91 |
chr12_79799402_79799702 | 10.03 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
125181 |
0.05 |
chr5_64812012_64812403 | 10.02 |
Klf3 |
Kruppel-like factor 3 (basic) |
132 |
0.95 |
chr13_43260715_43261023 | 10.01 |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
42536 |
0.15 |
chr10_62215401_62215586 | 9.99 |
Tspan15 |
tetraspanin 15 |
13716 |
0.15 |
chr13_55210517_55212032 | 9.94 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
267 |
0.89 |
chr9_44488742_44489142 | 9.88 |
Bcl9l |
B cell CLL/lymphoma 9-like |
1695 |
0.15 |
chr8_14996905_14997280 | 9.84 |
Arhgef10 |
Rho guanine nucleotide exchange factor (GEF) 10 |
956 |
0.42 |
chrX_13070554_13071574 | 9.83 |
Usp9x |
ubiquitin specific peptidase 9, X chromosome |
434 |
0.84 |
chr1_181246490_181246641 | 9.81 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
4245 |
0.17 |
chr14_98169050_98170231 | 9.80 |
Dach1 |
dachshund family transcription factor 1 |
97 |
0.98 |
chr8_94899608_94899958 | 9.73 |
Ccdc102a |
coiled-coil domain containing 102A |
17738 |
0.1 |
chr13_97240569_97241316 | 9.72 |
Enc1 |
ectodermal-neural cortex 1 |
163 |
0.95 |
chr11_3202493_3203344 | 9.69 |
Eif4enif1 |
eukaryotic translation initiation factor 4E nuclear import factor 1 |
77 |
0.95 |
chr8_125444976_125445153 | 9.68 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
47646 |
0.17 |
chr4_53595271_53595830 | 9.66 |
Slc44a1 |
solute carrier family 44, member 1 |
555 |
0.77 |
chr14_8244059_8244558 | 9.64 |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
2095 |
0.32 |
chr3_88532663_88533971 | 9.61 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chrX_94540282_94541447 | 9.59 |
Maged1 |
melanoma antigen, family D, 1 |
1126 |
0.39 |
chr19_53313026_53314073 | 9.56 |
Mxi1 |
MAX interactor 1, dimerization protein |
483 |
0.75 |
chr9_119469764_119470364 | 9.55 |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
25077 |
0.13 |
chr7_127777434_127777897 | 9.54 |
Setd1a |
SET domain containing 1A |
30 |
0.93 |
chr1_152902778_152903485 | 9.53 |
Smg7 |
Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) |
485 |
0.76 |
chr15_83432091_83432269 | 9.52 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
635 |
0.68 |
chr19_25138323_25138528 | 9.49 |
Dock8 |
dedicator of cytokinesis 8 |
11033 |
0.22 |
chr17_34592277_34593459 | 9.48 |
Pbx2 |
pre B cell leukemia homeobox 2 |
134 |
0.85 |
chr9_44343717_44344063 | 9.46 |
Hmbs |
hydroxymethylbilane synthase |
338 |
0.65 |
chr15_80634773_80634924 | 9.46 |
Gm49553 |
predicted gene, 49553 |
5610 |
0.14 |
chr7_127026546_127028177 | 9.46 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
324 |
0.58 |
chr7_30812412_30812642 | 9.44 |
Ffar2 |
free fatty acid receptor 2 |
8450 |
0.08 |
chr15_77203580_77203935 | 9.42 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
321 |
0.87 |
chr2_170133039_170133515 | 9.41 |
Zfp217 |
zinc finger protein 217 |
668 |
0.81 |
chr5_115522010_115522417 | 9.40 |
Pxn |
paxillin |
1908 |
0.17 |
chr19_24280041_24280837 | 9.40 |
Fxn |
frataxin |
129 |
0.96 |
chr13_91890302_91890496 | 9.39 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
13514 |
0.2 |
chr15_102240687_102240854 | 9.39 |
Rarg |
retinoic acid receptor, gamma |
2819 |
0.13 |
chr1_185454557_185455710 | 9.39 |
Slc30a10 |
solute carrier family 30, member 10 |
95 |
0.83 |
chr3_108096355_108096541 | 9.39 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
795 |
0.42 |
chr17_47754107_47754296 | 9.35 |
Tfeb |
transcription factor EB |
125 |
0.94 |
chr8_46847927_46848347 | 9.35 |
Gm45481 |
predicted gene 45481 |
14225 |
0.18 |
chr15_67116054_67116409 | 9.31 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
2239 |
0.39 |
chr15_83122033_83122905 | 9.30 |
Rrp7a |
ribosomal RNA processing 7 homolog A (S. cerevisiae) |
282 |
0.84 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 29.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
9.5 | 28.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
7.4 | 7.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
5.6 | 16.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
5.4 | 21.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
4.9 | 19.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
4.9 | 19.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
4.9 | 14.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.8 | 9.7 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
4.6 | 18.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
4.5 | 22.7 | GO:0072553 | terminal button organization(GO:0072553) |
4.4 | 22.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.3 | 12.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
4.1 | 16.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.0 | 16.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.9 | 31.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
3.9 | 11.7 | GO:0036166 | phenotypic switching(GO:0036166) |
3.9 | 11.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.8 | 15.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
3.8 | 15.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
3.8 | 11.3 | GO:0008050 | female courtship behavior(GO:0008050) |
3.6 | 25.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
3.5 | 20.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
3.4 | 6.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
3.3 | 9.8 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
3.3 | 9.8 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
3.3 | 9.8 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.3 | 9.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.3 | 9.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.3 | 9.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
3.2 | 22.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.2 | 9.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.2 | 25.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
3.2 | 12.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
3.2 | 19.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
3.1 | 12.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
3.1 | 24.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
3.1 | 6.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.0 | 3.0 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
2.9 | 8.8 | GO:0061010 | gall bladder development(GO:0061010) |
2.9 | 8.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.9 | 8.6 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
2.9 | 5.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.9 | 11.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.8 | 8.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.8 | 2.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.8 | 5.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.8 | 5.5 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.7 | 13.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.7 | 5.4 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.6 | 7.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.6 | 7.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.6 | 7.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.6 | 12.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.5 | 17.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.5 | 19.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.5 | 9.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.5 | 7.4 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.5 | 12.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.4 | 14.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.4 | 7.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
2.4 | 7.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.4 | 9.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.4 | 7.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.3 | 16.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.3 | 7.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.3 | 14.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.3 | 6.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.3 | 9.2 | GO:0003166 | bundle of His development(GO:0003166) |
2.3 | 9.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
2.3 | 18.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.3 | 6.8 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
2.2 | 9.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.2 | 6.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.2 | 11.0 | GO:0070836 | caveola assembly(GO:0070836) |
2.2 | 8.8 | GO:0019230 | proprioception(GO:0019230) |
2.2 | 8.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.2 | 6.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.2 | 8.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.1 | 6.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.1 | 8.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.1 | 6.3 | GO:0072718 | response to cisplatin(GO:0072718) |
2.1 | 4.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.0 | 6.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.0 | 10.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.0 | 6.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.0 | 6.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.0 | 6.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.0 | 4.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.9 | 9.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.9 | 5.7 | GO:0015793 | glycerol transport(GO:0015793) |
1.9 | 5.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.9 | 5.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.9 | 5.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.9 | 9.3 | GO:0006116 | NADH oxidation(GO:0006116) |
1.9 | 5.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.8 | 3.7 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
1.8 | 9.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.8 | 3.7 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.8 | 11.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.8 | 3.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.8 | 5.3 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.7 | 5.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.7 | 24.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.7 | 10.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.7 | 13.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.7 | 5.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.7 | 6.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.7 | 5.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.7 | 25.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.7 | 6.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.7 | 11.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.7 | 10.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.7 | 8.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.7 | 6.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.7 | 1.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.7 | 6.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.6 | 8.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.6 | 6.5 | GO:0008228 | opsonization(GO:0008228) |
1.6 | 8.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.6 | 3.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.6 | 4.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.6 | 6.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.6 | 1.6 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.6 | 11.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.6 | 4.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.6 | 15.8 | GO:0019985 | translesion synthesis(GO:0019985) |
1.6 | 4.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.6 | 3.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.6 | 1.6 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.6 | 6.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.6 | 7.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.6 | 7.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.5 | 20.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.5 | 10.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.5 | 1.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
1.5 | 6.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 7.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.5 | 7.6 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
1.5 | 4.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.5 | 4.5 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
1.5 | 10.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
1.5 | 5.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.5 | 8.8 | GO:0015871 | choline transport(GO:0015871) |
1.5 | 4.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.4 | 4.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.4 | 2.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.4 | 1.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.4 | 14.3 | GO:0034063 | stress granule assembly(GO:0034063) |
1.4 | 4.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.4 | 15.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.4 | 8.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.4 | 4.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.4 | 8.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.4 | 4.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.4 | 11.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 2.8 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.4 | 4.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.4 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 6.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.4 | 6.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.4 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.4 | 4.1 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.3 | 6.7 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.3 | 8.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.3 | 5.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.3 | 22.7 | GO:0031100 | organ regeneration(GO:0031100) |
1.3 | 2.7 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.3 | 5.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.3 | 6.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.3 | 2.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.3 | 2.6 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.3 | 6.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.3 | 2.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.3 | 7.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.3 | 5.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.3 | 3.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.3 | 5.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
1.3 | 5.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.3 | 2.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
1.3 | 10.0 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 3.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.2 | 7.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.2 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.2 | 3.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 9.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.2 | 4.9 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.2 | 3.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.2 | 3.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.2 | 3.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 6.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.2 | 6.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.2 | 2.4 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.2 | 11.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.2 | 1.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.2 | 5.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.2 | 10.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.2 | 1.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.2 | 18.6 | GO:0050779 | RNA destabilization(GO:0050779) |
1.2 | 2.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.2 | 2.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.2 | 4.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 5.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.1 | 4.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.1 | 4.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.1 | 2.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 4.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.1 | 3.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.1 | 2.3 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 3.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.1 | 2.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 3.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.1 | 3.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.1 | 4.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.1 | 2.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.1 | 1.1 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.1 | 2.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.1 | 5.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.1 | 4.5 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.1 | 5.5 | GO:0061042 | vascular wound healing(GO:0061042) |
1.1 | 7.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.1 | 4.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.1 | 2.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 2.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 2.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.1 | 4.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 4.3 | GO:0009597 | detection of virus(GO:0009597) |
1.1 | 6.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.1 | 3.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 3.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 2.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.0 | 1.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.0 | 6.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.0 | 5.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 9.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.0 | 4.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.0 | 3.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.0 | 12.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.0 | 2.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 3.0 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.0 | 4.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.0 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 2.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.0 | 6.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.0 | 7.0 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
1.0 | 3.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.0 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 2.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.0 | 10.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 3.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.0 | 6.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.0 | 5.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.0 | 2.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 2.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 2.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.0 | 6.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.0 | 4.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.0 | 1.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.0 | 1.9 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.0 | 1.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.0 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.0 | 2.9 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.0 | 1.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.9 | 0.9 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.9 | 5.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.9 | 12.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.9 | 2.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 6.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.9 | 2.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.9 | 0.9 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.9 | 9.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.9 | 23.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.9 | 5.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 36.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.9 | 11.0 | GO:0043486 | histone exchange(GO:0043486) |
0.9 | 6.4 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.9 | 5.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 1.8 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.9 | 2.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.9 | 3.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 3.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 1.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 8.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.9 | 2.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 2.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 23.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.9 | 3.5 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.9 | 4.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 1.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 1.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.9 | 0.9 | GO:0090009 | primitive streak formation(GO:0090009) |
0.9 | 2.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.9 | 6.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.9 | 5.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.9 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 3.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 6.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.9 | 6.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 1.7 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.9 | 2.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 3.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.8 | 6.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.8 | 5.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.8 | 2.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.8 | 3.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.8 | 2.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 5.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.8 | 2.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.8 | 1.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.8 | 0.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 1.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 2.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 3.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.8 | 2.5 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 0.8 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.8 | 53.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.8 | 2.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 5.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 1.6 | GO:0002434 | immune complex clearance(GO:0002434) |
0.8 | 2.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 7.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.8 | 3.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 2.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 3.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.8 | 3.9 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 9.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.8 | 0.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.8 | 14.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.8 | 1.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.8 | 1.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 3.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.8 | 3.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 2.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.8 | 12.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.7 | 3.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.7 | 2.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 4.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 3.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 6.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.7 | 4.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.7 | 17.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 2.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.7 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 1.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 9.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 5.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.7 | 2.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 1.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.7 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.7 | 2.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.7 | 7.9 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.7 | 2.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 2.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.7 | 8.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.7 | 0.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.7 | 6.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.7 | 4.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.7 | 7.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.7 | 2.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.7 | 2.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.7 | 5.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.7 | 20.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.7 | 1.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 4.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 7.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.7 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 1.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 1.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.7 | 17.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.7 | 15.6 | GO:0048538 | thymus development(GO:0048538) |
0.7 | 2.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.7 | 1.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.7 | 0.7 | GO:0002576 | platelet degranulation(GO:0002576) |
0.7 | 1.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.7 | 4.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.7 | 3.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 0.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.7 | 1.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.7 | 3.9 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.7 | 4.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.7 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 2.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.7 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.6 | 4.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 2.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 3.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.6 | 1.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 4.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.6 | 1.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 1.9 | GO:0030730 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.6 | 2.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 3.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 5.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 0.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.6 | 3.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.6 | 7.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.6 | 5.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.6 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 6.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 2.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.6 | 2.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.6 | 1.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.6 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 1.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.6 | 1.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 3.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.6 | 5.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.6 | 1.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.6 | 7.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.6 | 1.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 1.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.6 | 1.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.6 | 4.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 1.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.6 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 8.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.6 | 1.2 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.6 | 1.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 1.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.6 | 4.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.6 | 0.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 2.3 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.6 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.6 | 4.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 5.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.6 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 5.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 2.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 6.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 1.7 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.6 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.6 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 2.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.6 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.6 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 9.1 | GO:0072678 | T cell migration(GO:0072678) |
0.6 | 2.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.6 | 2.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.7 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.6 | 6.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 1.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.6 | 1.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 1.7 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 1.7 | GO:0009838 | abscission(GO:0009838) |
0.6 | 0.6 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.6 | 4.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 2.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 6.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 1.6 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.5 | 1.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 0.5 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.5 | 7.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 8.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 1.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 1.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 5.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 1.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 2.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.5 | 5.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.5 | 2.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 0.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 4.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 2.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 2.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 0.5 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 6.8 | GO:0048535 | lymph node development(GO:0048535) |
0.5 | 1.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 2.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 3.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.5 | 1.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 7.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 5.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.5 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 2.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 1.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.5 | 2.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 1.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 0.5 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.5 | 1.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 1.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 5.6 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
0.5 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 21.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.5 | 0.5 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.5 | 4.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 1.0 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 1.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 5.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 2.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 3.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 5.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.5 | 1.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 2.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.5 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 1.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 1.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.5 | 1.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.5 | 5.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 1.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.5 | 14.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.5 | 2.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 2.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 2.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 1.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 1.4 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.4 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.5 | 0.5 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.5 | 7.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 3.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.5 | 2.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 3.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.5 | 4.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 1.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.5 | 0.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 4.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 4.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 3.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 4.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 5.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 1.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 0.9 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.5 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 1.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 16.8 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.5 | 2.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 0.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 4.9 | GO:0009648 | photoperiodism(GO:0009648) |
0.4 | 1.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
0.4 | 8.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 16.9 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 0.4 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.4 | 13.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 0.9 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.4 | 1.3 | GO:0072666 | protein targeting to lysosome(GO:0006622) establishment of protein localization to vacuole(GO:0072666) |
0.4 | 0.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 1.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 2.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 3.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.4 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 0.4 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 12.3 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.4 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 0.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 2.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 8.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 3.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 2.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 1.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 0.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.4 | 3.4 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.4 | 4.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 7.6 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.4 | 4.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 0.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 9.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 1.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 5.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 3.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.4 | 1.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 7.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 4.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.4 | 2.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.4 | 2.5 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.4 | 1.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 4.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.4 | 1.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 4.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 0.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.4 | 2.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.8 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 9.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.4 | 2.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 0.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 4.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.4 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.4 | 1.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 1.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 1.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.4 | 3.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 25.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.4 | 0.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 3.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 1.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 3.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 2.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 0.4 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.4 | 4.2 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.4 | 5.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 0.4 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.4 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 1.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 1.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 4.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 0.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 1.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 4.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 3.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.4 | 1.8 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.4 | 1.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 1.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 2.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 2.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 0.4 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 3.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 1.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 2.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 1.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 8.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.4 | 6.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 0.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 1.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 0.4 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.4 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 7.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.3 | 0.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 1.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 4.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.3 | 1.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 1.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 1.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 1.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 2.7 | GO:0007127 | meiosis I(GO:0007127) |
0.3 | 0.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 2.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 1.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 1.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 12.7 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 17.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 4.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 6.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 2.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.3 | 3.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 0.3 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.7 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.3 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 2.6 | GO:0051591 | response to cAMP(GO:0051591) |
0.3 | 3.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 5.5 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 2.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 1.6 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 3.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 1.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 3.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 1.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 0.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.9 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.3 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 2.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.3 | 0.6 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.3 | 0.9 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 0.9 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.3 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 1.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 6.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.6 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.3 | 2.5 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 4.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.3 | 1.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 1.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 0.6 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 2.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 2.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 2.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.3 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.2 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.3 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 2.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 2.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 1.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 5.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.6 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.3 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 3.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 0.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 1.7 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 0.9 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 0.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 0.3 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 2.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 1.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.3 | 1.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.3 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.6 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.3 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 1.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 6.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 1.1 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.3 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.5 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.3 | 1.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 1.4 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.3 | 8.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.3 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 1.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 2.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 2.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 2.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 3.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 2.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.5 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 0.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.3 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 1.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.8 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.3 | 1.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 1.0 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 1.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 1.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 13.3 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.7 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 1.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 5.9 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.2 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 4.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 1.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 1.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 9.5 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 1.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 3.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 1.7 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.5 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.2 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.2 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 6.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.5 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.2 | 0.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 19.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 2.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.5 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 7.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 1.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 4.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 2.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 1.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.5 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.2 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.5 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.2 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 6.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 5.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 6.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 2.7 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.2 | 2.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 1.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 3.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.2 | 0.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 3.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 1.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.4 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 3.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 2.6 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.2 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.6 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.4 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.2 | 0.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.4 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 6.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.6 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.2 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.2 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 5.3 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 1.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 4.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.8 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 2.8 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.6 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.4 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 0.6 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.2 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 2.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 2.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 4.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 1.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 2.5 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 2.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 1.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.2 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.2 | 0.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.2 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.9 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 2.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 2.7 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.2 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.7 | GO:0002488 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 2.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.2 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 2.8 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 0.2 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 1.2 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 1.8 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.2 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 1.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.2 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.6 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.5 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.2 | 4.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 0.5 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 2.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 21.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.2 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 4.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.2 | 0.5 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.2 | 0.3 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 2.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.5 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.9 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 4.8 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 2.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 1.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 2.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 26.7 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 2.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 2.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 1.9 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 2.7 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 3.9 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.5 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 1.9 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 3.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 0.1 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.1 | 0.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:1990182 | exosomal secretion(GO:1990182) |
0.1 | 0.6 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.2 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 1.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 2.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0042440 | pigment metabolic process(GO:0042440) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 1.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0044252 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.1 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 2.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 8.3 | GO:0032259 | methylation(GO:0032259) |
0.1 | 4.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.7 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.6 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.0 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 3.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 2.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:2000054 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.6 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.3 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 7.5 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.4 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 12.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.6 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.7 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.5 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.6 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 1.3 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.6 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 3.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 0.1 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.6 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.5 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.1 | 0.7 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.1 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0071600 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0090317 | negative regulation of intracellular protein transport(GO:0090317) |
0.0 | 0.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.6 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.0 | 0.1 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.7 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.0 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.0 | 0.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.1 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.0 | 0.0 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.0 | 0.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.0 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.0 | 3.4 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.8 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.0 | 0.0 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.0 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 24.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.4 | 44.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
3.4 | 30.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.7 | 10.9 | GO:0005642 | annulate lamellae(GO:0005642) |
2.7 | 8.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.5 | 5.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.4 | 7.3 | GO:1990635 | proximal dendrite(GO:1990635) |
2.2 | 11.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.1 | 17.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.1 | 6.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.1 | 6.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.0 | 8.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.9 | 68.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.9 | 1.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.8 | 9.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.8 | 12.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.7 | 5.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.6 | 11.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.6 | 14.5 | GO:0071439 | clathrin complex(GO:0071439) |
1.6 | 11.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.6 | 6.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.6 | 20.4 | GO:0031528 | microvillus membrane(GO:0031528) |
1.5 | 6.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 32.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.5 | 5.8 | GO:0001940 | male pronucleus(GO:0001940) |
1.4 | 4.3 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 5.7 | GO:0042825 | TAP complex(GO:0042825) |
1.4 | 5.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.4 | 5.6 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 6.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 20.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 25.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.3 | 5.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.3 | 8.0 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 21.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.3 | 3.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.3 | 10.3 | GO:0070652 | HAUS complex(GO:0070652) |
1.3 | 8.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 1.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 5.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 9.3 | GO:0001650 | fibrillar center(GO:0001650) |
1.2 | 2.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.1 | 3.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.1 | 11.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.1 | 10.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.1 | 10.9 | GO:0031932 | TORC2 complex(GO:0031932) |
1.1 | 7.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.1 | 5.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 4.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.0 | 25.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 38.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.0 | 4.2 | GO:0008091 | spectrin(GO:0008091) |
1.0 | 4.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.0 | 4.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.0 | 8.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.0 | 18.2 | GO:0002102 | podosome(GO:0002102) |
1.0 | 5.0 | GO:0033503 | HULC complex(GO:0033503) |
1.0 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
1.0 | 13.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.0 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
1.0 | 39.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.0 | 2.9 | GO:0030056 | hemidesmosome(GO:0030056) |
1.0 | 67.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.0 | 63.1 | GO:0016363 | nuclear matrix(GO:0016363) |
1.0 | 12.4 | GO:0000786 | nucleosome(GO:0000786) |
1.0 | 2.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.9 | 8.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.9 | 2.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 2.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 1.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.9 | 22.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.9 | 9.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 4.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 2.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.9 | 16.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 5.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 7.7 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 2.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 2.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.8 | 10.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.8 | 4.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.8 | 7.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.8 | 24.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 6.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.8 | 7.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.8 | 5.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 4.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 7.9 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 0.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.8 | 4.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 3.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 35.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 5.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 3.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 28.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 5.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 2.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 3.5 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 7.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.7 | 6.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 4.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 7.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.7 | 2.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 4.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 3.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 7.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.6 | 2.6 | GO:0099738 | cell cortex region(GO:0099738) |
0.6 | 13.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 11.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 1.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 1.8 | GO:0000811 | GINS complex(GO:0000811) |
0.6 | 6.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 2.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.6 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 4.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.6 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 9.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.6 | 106.2 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 1.7 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 13.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 4.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 4.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 5.1 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 13.6 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 3.4 | GO:0000801 | central element(GO:0000801) |
0.6 | 4.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 0.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 3.4 | GO:0042599 | lamellar body(GO:0042599) |
0.6 | 3.4 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 31.3 | GO:0005902 | microvillus(GO:0005902) |
0.5 | 40.1 | GO:0030496 | midbody(GO:0030496) |
0.5 | 1.1 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 2.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 4.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 2.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 5.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 1.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 27.1 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 45.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 3.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 8.0 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 64.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 16.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.5 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 2.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 18.6 | GO:0016605 | PML body(GO:0016605) |
0.4 | 1.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 0.9 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 1.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 11.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 1.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 26.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 12.9 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 2.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 2.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 8.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 3.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 492.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 3.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 1.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.4 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 11.0 | GO:0005844 | polysome(GO:0005844) |
0.4 | 3.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 1.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 36.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 12.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 2.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.3 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 4.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 15.0 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 3.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 2.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 6.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 4.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 1.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 1.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 2.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 4.2 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.8 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.3 | 54.5 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 1.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 10.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.7 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 2.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 27.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 9.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 2.9 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 7.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 21.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 2.8 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 4.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 8.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 8.3 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 2.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 2.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 6.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 32.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.2 | 4.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 7.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 55.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 7.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 15.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 11.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 2.0 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 45.1 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 2.4 | GO:0043205 | fibril(GO:0043205) |
0.2 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 1.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 3.0 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 4.0 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.3 | GO:0097451 | astrocyte end-foot(GO:0097450) glial limiting end-foot(GO:0097451) |
0.2 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 9.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 8.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 90.2 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 4.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 12.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 220.9 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 2.8 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.2 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 4.4 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 6.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 35.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 0.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 8.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
7.7 | 30.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
5.6 | 16.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
5.5 | 16.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.7 | 14.0 | GO:1990188 | euchromatin binding(GO:1990188) |
3.6 | 10.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
3.4 | 17.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.2 | 25.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
3.0 | 9.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
3.0 | 20.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.9 | 8.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
2.8 | 8.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.8 | 8.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.8 | 46.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.7 | 8.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.7 | 8.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.7 | 8.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.7 | 8.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.6 | 7.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.6 | 29.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.6 | 7.7 | GO:0030519 | snoRNP binding(GO:0030519) |
2.6 | 7.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.6 | 5.1 | GO:0043398 | HLH domain binding(GO:0043398) |
2.4 | 7.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.4 | 7.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
2.4 | 9.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.4 | 7.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
2.4 | 11.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.3 | 6.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.2 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.2 | 8.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.2 | 8.7 | GO:0043426 | MRF binding(GO:0043426) |
2.2 | 6.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.1 | 10.7 | GO:0016530 | metallochaperone activity(GO:0016530) |
2.0 | 6.1 | GO:0050692 | DBD domain binding(GO:0050692) |
2.0 | 9.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.0 | 13.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.0 | 7.9 | GO:0051425 | PTB domain binding(GO:0051425) |
1.9 | 7.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.9 | 1.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.9 | 48.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.8 | 1.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.8 | 9.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.8 | 7.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.8 | 3.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 36.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.7 | 6.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.7 | 5.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.7 | 9.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.6 | 19.3 | GO:0019177 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
1.6 | 6.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.5 | 4.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.5 | 16.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.5 | 6.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.5 | 3.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.5 | 6.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.4 | 7.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.4 | 7.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.4 | 5.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.4 | 10.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.4 | 17.0 | GO:0017166 | vinculin binding(GO:0017166) |
1.4 | 1.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.4 | 18.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.4 | 5.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.4 | 7.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.4 | 9.7 | GO:0034046 | poly(G) binding(GO:0034046) |
1.4 | 8.3 | GO:0050733 | RS domain binding(GO:0050733) |
1.4 | 40.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.4 | 2.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.4 | 6.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.3 | 42.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.3 | 5.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 13.3 | GO:0031996 | thioesterase binding(GO:0031996) |
1.3 | 4.0 | GO:0048030 | disaccharide binding(GO:0048030) |
1.3 | 63.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.3 | 3.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.3 | 5.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.3 | 2.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.3 | 10.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.3 | 1.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.2 | 15.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.2 | 8.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.2 | 17.3 | GO:0018748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.2 | 12.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.2 | 3.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.2 | 7.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.2 | 4.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 3.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.2 | 29.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.2 | 21.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.2 | 4.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.1 | 5.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.1 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.1 | 3.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 4.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.1 | 11.0 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 6.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 6.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 4.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.1 | 5.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.1 | 3.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 2.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.1 | 4.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.1 | 7.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.1 | 10.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.0 | 3.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 5.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 4.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.0 | 3.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.0 | 3.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 7.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 6.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.0 | 3.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.0 | 4.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 3.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 2.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 5.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.0 | 12.8 | GO:0031491 | nucleosome binding(GO:0031491) |
1.0 | 5.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 3.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.0 | 9.7 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.0 | 3.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 2.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.0 | 2.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.9 | 10.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 2.8 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.9 | 13.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.9 | 22.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.9 | 2.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.9 | 5.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.9 | 1.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 4.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 26.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.9 | 6.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 12.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 6.2 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 0.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.9 | 1.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.9 | 4.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.9 | 10.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.9 | 11.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 8.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.8 | 8.5 | GO:0016208 | AMP binding(GO:0016208) |
0.8 | 6.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 18.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 4.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.8 | 12.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.8 | 2.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 6.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 5.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 15.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 7.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 3.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 37.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.8 | 2.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 4.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 2.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 23.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.8 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 1.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 3.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.8 | 2.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 3.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.8 | 18.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 4.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 3.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 7.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.8 | 3.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 0.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 3.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 11.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.8 | 13.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.8 | 1.5 | GO:0004096 | catalase activity(GO:0004096) |
0.8 | 2.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 4.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 2.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 3.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.8 | 3.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 2.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 3.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.7 | 3.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 0.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.7 | 2.9 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 1.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 2.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 10.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.7 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 10.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 8.7 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 7.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 2.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 1.4 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.7 | 6.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 8.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.7 | 4.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.7 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 3.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 1.4 | GO:0032564 | dATP binding(GO:0032564) |
0.7 | 2.7 | GO:0032041 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 4.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 6.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 27.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.7 | 2.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 5.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 5.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.7 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 6.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 5.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 3.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 1.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 4.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 15.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 2.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 2.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 4.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 8.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 125.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.6 | 3.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 5.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.6 | 3.7 | GO:0015288 | porin activity(GO:0015288) |
0.6 | 6.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.6 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 22.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.6 | 6.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 3.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 2.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 2.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 1.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 7.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 13.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 1.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.6 | 23.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.6 | 4.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 2.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.6 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 1.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 2.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 4.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 1.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.6 | 2.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 3.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 4.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 1.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 2.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 2.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 6.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 4.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 2.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.5 | 144.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.5 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 1.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 2.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 2.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 2.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 5.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 10.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 5.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.5 | 1.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 1.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.5 | 3.8 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.5 | 4.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 6.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.5 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 0.9 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 7.9 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 2.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 5.5 | GO:0043176 | amine binding(GO:0043176) |
0.5 | 103.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.5 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 4.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 37.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.4 | 0.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 7.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 8.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 10.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 2.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 2.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 0.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 1.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 2.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 16.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 1.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 2.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.4 | 0.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 2.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 10.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.4 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 8.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.4 | 1.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 19.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 1.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 9.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.5 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 19.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.5 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 4.1 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 7.7 | GO:0052635 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.4 | 0.7 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.4 | 2.9 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.4 | 2.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 2.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 3.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 4.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 2.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 3.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 3.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 2.0 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 0.3 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 2.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 3.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 0.6 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 2.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 1.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 5.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 0.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 3.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 3.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 3.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.3 | 0.9 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 20.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 2.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 3.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 2.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 0.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 3.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.3 | 4.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.3 | 2.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 2.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 0.8 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 9.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 1.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 4.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 2.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 13.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 1.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.3 | 29.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 3.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 0.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.0 | GO:0016443 | ribonuclease III activity(GO:0004525) bidentate ribonuclease III activity(GO:0016443) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.2 | 10.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 19.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.9 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 3.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 2.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 2.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 6.3 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.1 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.2 | 4.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 1.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 167.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.9 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 6.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 12.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 51.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 5.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 1.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 3.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 0.4 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 4.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 5.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 13.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.9 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 4.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 6.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 2.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 3.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 7.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 2.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 2.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 5.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.9 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 3.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 3.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0034806 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 3.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 3.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 3.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 17.1 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 4.4 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 5.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.2 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 14.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 6.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 2.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 3.1 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.9 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 17.7 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 1.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 1.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | ST STAT3 PATHWAY | STAT3 Pathway |
1.9 | 55.2 | PID IGF1 PATHWAY | IGF1 pathway |
1.9 | 105.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.8 | 26.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.7 | 45.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.7 | 16.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.5 | 22.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.4 | 25.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.4 | 29.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.4 | 22.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.4 | 26.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.4 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.2 | 30.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.2 | 17.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.1 | 3.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.1 | 11.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.1 | 10.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.1 | 19.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.1 | 42.4 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 53.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 16.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 49.6 | PID P73PATHWAY | p73 transcription factor network |
1.0 | 6.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 3.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 22.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.9 | 9.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.9 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.9 | 23.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.9 | 25.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.9 | 10.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 35.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.8 | 8.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 8.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 15.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 32.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.8 | 4.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 1.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 12.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 14.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.7 | 2.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 3.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 11.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.7 | 7.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 20.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 8.7 | PID MYC PATHWAY | C-MYC pathway |
0.7 | 32.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 5.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 2.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 6.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 5.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 16.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 3.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 4.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 18.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 13.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 10.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 5.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.5 | 11.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 11.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 9.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 5.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 3.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.5 | 1.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 9.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 7.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 5.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 5.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 5.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 5.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 9.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 4.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 12.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 5.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 12.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 4.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 3.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 7.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 7.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 38.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 2.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 2.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 3.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 5.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 5.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 2.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 6.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 3.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 3.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 4.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 3.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 4.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 6.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 72.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.1 | 10.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.0 | 44.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
2.0 | 48.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.8 | 44.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.7 | 15.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.6 | 11.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.4 | 42.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.4 | 12.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.4 | 17.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.3 | 13.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.3 | 22.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.3 | 11.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 10.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 3.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.2 | 19.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.2 | 18.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.2 | 8.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.2 | 18.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.2 | 4.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.2 | 21.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.2 | 28.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 9.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.1 | 18.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.1 | 22.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 17.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.1 | 25.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 19.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.1 | 19.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.0 | 14.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.0 | 10.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 19.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.0 | 5.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 12.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 11.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 25.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.9 | 9.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 6.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 14.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 66.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.9 | 0.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.9 | 8.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.9 | 3.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 18.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.8 | 9.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 9.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.8 | 8.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 5.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 25.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 3.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.7 | 5.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 11.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 10.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 17.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 10.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.7 | 13.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 2.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 3.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 6.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 9.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.6 | 6.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 11.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 3.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.6 | 4.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 1.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 5.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 5.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 6.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 45.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 2.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.6 | 49.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.6 | 8.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.6 | 6.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 22.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 10.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 4.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 6.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.5 | 13.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 2.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 1.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.5 | 6.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 27.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 4.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 5.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 3.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 10.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 3.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 3.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 4.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 6.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 15.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 14.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 3.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 4.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 14.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.4 | 3.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 3.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 15.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 4.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 6.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 45.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 6.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 2.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 2.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 3.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 10.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 2.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 15.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 2.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 2.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 5.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 15.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 5.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 5.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 1.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 9.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 1.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 8.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 1.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.3 | 4.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 3.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 2.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 6.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 5.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 3.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 8.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 4.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 4.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 5.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 4.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 2.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 6.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 14.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 6.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.9 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.9 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |